TCL Archive With NIH “Accountability” As Background, Advocates Support Budget Increases. March 30, 2001
TCL Archive NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer August 26, 2005
TCL Archive ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market September 26, 1997